Scarica l'app Stockscreener
21.60
1.46%
-0.32
Dopo l'orario di chiusura:
21.59
-0.01
-0.05%
Precedente Chiudi:
$21.92
Aprire:
$21.6
Volume 24 ore:
58,806
Relative Volume:
0.54
Capitalizzazione di mercato:
$312.68M
Reddito:
$1.80M
Utile/perdita netta:
$1.76B
Rapporto P/E:
0.182
EPS:
118.674
Flusso di cassa netto:
$-149.23M
1 W Prestazione:
-6.41%
1M Prestazione:
+47.24%
6M Prestazione:
+59.06%
1 anno Prestazione:
+48.25%
Intervallo 1D:
$21.37
$22.24
Intervallo di 1 settimana:
$21.37
$25.29
Portata 52W:
$10.80
$25.29
Inhibrx Biosciences Inc Stock (INBX) Company Profile
Nome
Inhibrx Biosciences Inc
Settore
Industria
Telefono
(858) 795-4220
Indirizzo
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
Confronta INBX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INBX
Inhibrx Biosciences Inc
|
21.60 | 317.31M | 1.80M | 1.76B | -149.23M | 118.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Inhibrx Biosciences Inc Stock (INBX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-23 | Iniziato | JMP Securities | Mkt Perform |
| 2024-01-23 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-03-16 | Iniziato | SMBC Nikko | Outperform |
| 2021-09-21 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-09-14 | Iniziato | Credit Suisse | Outperform |
| 2020-09-14 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Inhibrx Biosciences Inc Borsa (INBX) Ultime notizie
When is Inhibrx Biosciences Inc. stock expected to show significant growthPhenomenal investment performance - jammulinksnews.com
Should I hold or sell Inhibrx Biosciences Inc. stock in 2025Robust investment performance - jammulinksnews.com
Inhibrx Biosciences Inc. Company Revenue and Profit Trends: A Deep DiveFree Daily Volume Spike Trading Signals - Newser
Will Inhibrx Biosciences Inc. outperform the marketConservative Asset Allocation Risk Analysis - Newser
Has Inhibrx Biosciences Inc. Stock Ever Crashed Historical Volatility ReviewStrategy Builder for Growth Focused Traders - Newser
What’s the recovery path for long term holders of Inhibrx Biosciences Inc.Risk-Managed Trade Alerts for Consistency - Newser
Risk adjusted return profile for Inhibrx Biosciences Inc. analyzedIntraday Price Action Forecast Planner - Newser
Published on: 2025-08-01 16:27:04 - metal.it
Why Inhibrx Biosciences Inc. stock attracts strong analyst attentionShort Term Gain Strategy with AI Logic - Newser
Inhibrx Biosciences Inc. stock prediction for this weekQuick Profit Setup with Signal Forecast - Newser
What moving averages say about Inhibrx Biosciences Inc.Price Forecast Based on AI Analysis - Newser
Intrinsic Value of Inhibrx Biosciences Inc. Stock: Is It Undervalued or OvervaluedBuy Strategy with Smart Exit Timing - Newser
Tools to assess Inhibrx Biosciences Inc.’s risk profileEntry Timing with Downside Risk Analysis - Newser
How Inhibrx Biosciences Inc. stock performs during market volatilityIn-Depth Stock Trading Volume Analysis - Newser
How does Inhibrx Biosciences Inc. compare to its industry peersFinancial News Tips To Watch Now - jammulinksnews.com
Sectors Driving Future Growth for Inhibrx Biosciences Inc. StockLong-Term Allocation Strategy Summary Breakdown - Newser
Reversal indicators forming on Inhibrx Biosciences Inc. stockEarly Entry Planner for Swing Candidates - Newser
New Product Launches: Will They Boost Inhibrx Biosciences Inc. Stock in 2025Real Trader Watchlist of Hot Stocks Released - metal.it
Is Inhibrx Biosciences Inc. Starting a New UptrendHigh Yield Stock Screening Results Explained - metal.it
Bollinger Bands Show Potential Breakout in Inhibrx Biosciences Inc.Oversold Recovery Opportunity Stocks Attract Buyers - metal.it
Inhibrx Biosciences Inc. Nearing Breakout Level After BounceInvestment Plan With Growth Optimization Finalized - metal.it
Inhibrx Biosciences Inc. Flashes Rebound Signal in Oversold ConditionAI Screening for Swing Trade Picks Finds Momentum - metal.it
Is Inhibrx Biosciences Inc. Forming a Consolidation BaseTechnical Stock Breakout Predictions Signal Entry Points - metal.it
What makes Inhibrx Biosciences Inc. stock price move sharplyTechnical Screener for High Growth Stocks - Newser
Is Inhibrx Biosciences Inc. the Top Chart Pick This WeekHigh Accuracy Alerts for ROI Traders Detected - metal.it
Trend Reversal Possible in Inhibrx Biosciences Inc. Charts IndicateTechnical Stock Breakout Predictions Signal Entry Points - metal.it
How does Inhibrx Biosciences Inc. generate profit in a changing economyUnlock expert trading strategies for growth - jammulinksnews.com
What are Inhibrx Biosciences Inc. company’s key revenue driversMaster stock selection with insider knowledge - jammulinksnews.com
Inhibrx Biosciences Advances HexAgon-HN Study for Head, Neck Cancer - Insider Monkey
How strong is Inhibrx Biosciences Inc. company’s balance sheetGet exclusive access to premium stock research - jammulinksnews.com
Is Inhibrx Biosciences Inc. a growth stock or a value stockGame-changing capital returns - jammulinksnews.com
Inhibrx Biosciences Inc. stock trendline breakdownDividend Strategy Summary With 10-Year Outlook - Newser
Inhibrx Biosciences Inc. stock prediction for this week Technical Confirmation System with Signal Alerts - Newser
What are analysts’ price targets for Inhibrx Biosciences Inc. in the next 12 monthsHigh-velocity gains - jammulinksnews.com
What institutional investors are buying Inhibrx Biosciences Inc. stockAchieve breakthrough investment performance - jammulinksnews.com
Does Inhibrx Biosciences Inc. stock perform well during market downturnsUnlock exclusive trading strategies for gains - jammulinksnews.com
Inhibrx Biosciences Inc Azioni (INBX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Inhibrx Biosciences Inc Azioni (INBX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kayyem Jon Faiz | Director |
Nov 20 '24 |
Buy |
14.19 |
37,500 |
532,204 |
69,843 |
| Lappe Mark | Chief Executive Officer |
Sep 12 '24 |
Buy |
15.05 |
26,963 |
405,793 |
692,511 |
| Lappe Mark | Chief Executive Officer |
Sep 16 '24 |
Buy |
17.13 |
13,037 |
223,324 |
705,548 |
| Vuori Kristiina MD | Director |
Sep 11 '24 |
Buy |
15.07 |
6,457 |
97,307 |
13,776 |
| Vuori Kristiina MD | Director |
Sep 10 '24 |
Buy |
15.00 |
179 |
2,685 |
7,319 |
| Lappe Mark | Chief Executive Officer |
Sep 06 '24 |
Buy |
15.29 |
26,000 |
397,540 |
647,548 |
| Lappe Mark | Chief Executive Officer |
Sep 09 '24 |
Buy |
15.21 |
9,500 |
144,495 |
657,048 |
| Lappe Mark | Chief Executive Officer |
Sep 10 '24 |
Buy |
15.19 |
8,500 |
129,115 |
665,548 |
| Lappe Mark | Chief Executive Officer |
Sep 03 '24 |
Buy |
15.81 |
20,000 |
316,263 |
165,000 |
| Lappe Mark | Chief Executive Officer |
Aug 29 '24 |
Buy |
14.03 |
10,000 |
140,300 |
135,000 |
0.93%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):